No Regional Disparities in Sofosbuvir Plus Ribavirin Therapy for HCV Genotype 2 Infection in Tochigi Prefecture and Its Vicinity

OBJECTIVE: Regional disparities were observed in the outcomes of interferon (IFN)-based therapy for chronic hepatitis C virus (HCV) infection in a Japanese nationwide study. However, whether or not these regional disparities are observed in the outcomes of direct-acting antiviral drugs, including so...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Intern Med
Autors principals: Hirosawa, Takuya, Morimoto, Naoki, Miura, Kouichi, Tahara, Toshiyuki, Murohisa, Toshimitsu, Okamura, Yukishige, Sato, Takashi, Numao, Norikatsu, Imai, Masato, Tano, Shigeo, Murayama, Kozue, Kurata, Hidekazu, Ozawa, Iwao, Fukaya, Yukimura, Yoshizumi, Hiroaki, Watanabe, Shunji, Tsukui, Mamiko, Takaoka, Yoshinari, Nomoto, Hiroaki, Isoda, Norio, Yamamoto, Hironori
Format: Artigo
Idioma:Inglês
Publicat: The Japanese Society of Internal Medicine 2018
Matèries:
Original Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6421161/
https://ncbi.nlm.nih.gov/pubmed/30333396
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2169/internalmedicine.1194-18
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars